Brivumen

Medicinal product

(Invented) name

Brivumen

Active substance (s)

Brivudinas

Strength

125 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AB15, Brivudine

Marketing authorisation holder

Berlin-Chemie AG (Menarini Group), Vokietija

Date of authorisation

2002-05-08

Date of renewal

2011-05-23

Documents

2473_1_2 Brivumen tab RPP 160526.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Brivudinas	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
3295	8778	1008778	lizdinė plokštelė	N1		Receptinis	LT/1/02/2473/001	Netiekiama	-	-	No	-	-
3296	8779	1008779	lizdinė plokštelė	N7		Receptinis	LT/1/02/2473/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-04-29	Išregistruotas
2011-05-23	Perregistruotas
2002-05-08	Registruotas